AI-Driven Biocatalysis Solutions

Why AI for Biocatalysis?

Industrial biocatalysis has matured beyond niche applications into a mainstream manufacturing technology. Yet the gap between identifying a biocatalytic opportunity and deploying a process-ready enzyme remains substantial. Traditional development timelines—12 to 24 months from enzyme identification to pilot-scale validation—are incompatible with competitive product launch schedules.

AI-driven approaches compress this timeline by prioritizing high-probability enzyme candidates before experimental commitment, designing variants optimized for process conditions rather than biological function, and predicting process behavior from molecular properties. The result is faster convergence on biocatalysts that are not merely active, but manufacturable, stable, and economically viable under industrial conditions.

The business case extends beyond speed. AI-guided development reduces the number of experimental variants requiring synthesis and screening, lowering reagent and personnel costs. It identifies process-compatible enzymes earlier, reducing late-stage failure risk. And it enables biocatalytic routes to molecules previously inaccessible to enzymatic transformation, opening new product categories and intellectual property positions.

Biocatalyst Development Platform

Our platform integrates enzyme discovery, engineering, and process characterization into a unified development pipeline:

Each stage feeds the next with quantitative data, ensuring that development decisions are grounded in measured performance rather than assumptions.

Industrial Workflow Optimization

Biocatalyst performance must be evaluated in process context, not just in assay tubes. Our workflow optimization addresses the full manufacturing chain:

Reaction Engineering: Optimization of substrate concentration, cofactor regeneration, product inhibition management, and downstream integration to maximize volumetric productivity and space-time yield

Immobilization and Formulation: Selection and optimization of carrier materials, crosslinking chemistries, and storage conditions to extend operational life and enable catalyst reuse

Process Analytical Integration: Development of in-process monitoring methods for enzyme activity, substrate conversion, and product quality to support real-time process control

Technology Transfer: Documentation and support for transfer from development to manufacturing, including standard operating procedures, quality specifications, and regulatory filing support

The objective is not merely an improved enzyme, but an improved process that happens to be enzymatic.

Our Biocatalysis Services

Our biocatalysis service is organized into three specialized tracks:

Sustainability & Green Chemistry

Biocatalysis offers intrinsic sustainability advantages that align with corporate environmental objectives and regulatory trends:

AI-guided development amplifies these advantages by identifying enzymes that are inherently more efficient and process-compatible, reducing the environmental footprint of both the development process and the final manufacturing operation.

Application Industries

Our AI-driven biocatalysis solutions support diverse industrial sectors:

Related Biocatalysis Services

Creative Enzymes also provides integrated biocatalysis development services, including enzyme screening, catalytic optimization, process compatibility analysis, enzyme immobilization, and industrial biotransformation support for AI-assisted biocatalyst engineering projects.

• Biocatalysis Services
• Biocatalyst Substrate Selection & Modification
• Biocatalyst Characterization
• Biocatalyst Gene Discovery & Expression
• Biocatalyst Engineering
• Biocatalytic Reaction Route Development
• Biocatalyst Production Process Development & Consulting

Case Example

AI-Driven Engineering of Sustainable Transaminases

Figure 1. AI-assisted protein engineering workflow for improving R-transaminase activity toward the pro-sitagliptin ketone. (Kumar et al., 2026)

This study developed a sustainable biocatalytic process for producing an industrially important chiral amine using AI-guided enzyme engineering. Researchers created a 6D-grid protein-engineering framework integrating interaction energy analysis, solvent effects, and 1.39 million structural fragments to predict productive mutations while minimizing experimental screening. Five AI-selected transaminase variants containing nine mutations each demonstrated high solubility and catalytic stability at a 7 L fermentation scale. The engineered enzymes converted a prochiral ketone to sitagliptin with over 99% enantiomeric excess and up to 89% conversion after scale-up. Additionally, replacing DMSO with a greener ethanol/PEG-400 solvent system improved sustainability while maintaining industrially relevant catalytic performance.

FAQs

• Q: What is the typical development timeline?

  A: 8–12 months from project initiation to pilot-scale validation for moderate-complexity targets. Novel activities or challenging process conditions may extend to 18 months. Expedited programs with compressed milestones are available.

• Q: Do you provide manufacturing-scale enzyme supply?

  A: We deliver optimized expression strains and purification protocols suitable for technology transfer to manufacturing. Commercial enzyme supply arrangements can be established through partner networks or client-specified manufacturers.

• Q: Can you work with proprietary substrates and products?

  A: Yes. All projects operate under confidentiality agreements. Proprietary structures and process conditions are protected, and client IP positions are respected throughout development.

• Q: What if no natural enzyme exists for my target reaction?

  A: We evaluate related enzyme classes for promiscuous activity that can be engineered toward the target transformation. For truly novel reactions, generative de novo enzyme design may be applicable, with extended development timelines.

• Q: How do you handle process integration?

  A: Process engineering is integral to our development workflow, not a downstream add-on. Enzyme engineering targets are defined in collaboration with process chemists to ensure compatibility with existing or planned manufacturing infrastructure.

• Q: Do you support regulatory filings?

  A: We provide characterization data, process descriptions, and quality documentation suitable for regulatory submission. Direct regulatory support is coordinated with client regulatory affairs teams or specialized consultants.